AML developmentExpanded leukemic stem cell (Lin−/Sca-1+/c-Kit+) populationsNo apoptotic cellsMalignant disease with a penetrance of around 80% and a latency period of 3 to 6 months. This evidence concerns the gene KIT and acute myeloid leukemia.